Schrodinger

SDGRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.358 B

$18.16 +1.97%

Close of 7 Aug 2026

Revenue

$255.9M

#2207 by revenue

Earnings

-$103.3M

Loss-making

Shares outstanding

74,352,857

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#144Lb PharmaceuticalsLBRX$1.38B
#145Xeris BiopharmaXERS$1.37B
#146SchrodingerSDGR$1.36B
#147MoonLake ImmunotherapeuticsMLTX$1.34B
#148MannkindMNKD$1.32B

Where these numbers come from

Share counts and financials for Schrodinger are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.